Skip to main content
Top
Published in: BMC Public Health 1/2024

Open Access 01-12-2024 | Research

The burden of Cardiovascular diseases in Jordan: a longitudinal analysis from the global burden of disease study, 1990–2019

Authors: Yazan A. Al-Ajlouni, Omar Al Ta’ani, Ghaith Shamaileh, Yazan Nagi, Mohammad Tanashat, Farah Al-Bitar, Dustin T. Duncan, Nour Makarem

Published in: BMC Public Health | Issue 1/2024

Login to get access

Abstract

Background

Cardiovascular Disease (CVD) is the leading cause of mortality worldwide. While countries in the Arab world continue to lack public health data and be severely understudied in health research, previous research has shown that compared to 1990, CVDs had a higher burden of disease in the Arab World in 2010. Jordan, a middle-income Arab country, is profiled with unique attributes such as a dual-sector healthcare system, political stability, and its role as a haven for refugees and migrants. These distinctive factors emphasize Jordan’s suitability as a case study. This investigation aims to quantify CVD burden in Jordan and identify risk factors, contributing to a broader understanding of health challenges in the Arab region and beyond.

Methods

The Global Burden of Disease (GBD) dataset was used to estimate prevalence, death, and disability-adjusted life-years (DALYs) as age-standardized rates from 1990 to 2019. We calculated percentage change for nine specific CVDs and reported trends by gender and age groups. Additionally, data on twelve a priori selected behavioral, clinical, and environmental risk factors attributing to overall age-standardized CVDs DALY were reported per 100,00 population.

Results

In 2019, the age-standardized CVD prevalence, death, and DALYs rates in Jordan were 7980 (95% uncertainty interval [UI] 7629, 8360), 248 (95% UI 211, 288), and 4647 (95% UI 4028, 5388), respectively. Despite an increase in the absolute number of mortality and prevalence, between 1990 and 2019, the age-standardized prevalence, death, and DALYs rates all decreased by 5.5%, 45.1%, and 46.7%, respectively. In 2019, the leading risk factors contributing to overall age-standardized CVDs DALY per 100,000 population were high systolic blood pressure, high BMI, dietary risks, and high LDL cholesterol.

Conclusion

Despite decreasing burden rate of CVDs in Jordan between 1990 and 2019, CVDs remain the leading cause of mortality in Jordan, with an increase in the total number of prevalence and mortality. Overall, this contributes to increased healthcare costs. Further research is required to quantify the burden of CVDs and understand it better. Intervention measures and policies tailored to specific CVDs should be designed to reduce the burden of CVDs in Jordan.
Literature
1.
go back to reference Ali S, Misganaw A, Worku A, Destaw Z, Negash L, Bekele A, et al. The burden of cardiovascular diseases in Ethiopia from 1990 to 2017: evidence from the global burden of Disease Study. Int Health. 2021;13(4):318–26.PubMedCrossRef Ali S, Misganaw A, Worku A, Destaw Z, Negash L, Bekele A, et al. The burden of cardiovascular diseases in Ethiopia from 1990 to 2017: evidence from the global burden of Disease Study. Int Health. 2021;13(4):318–26.PubMedCrossRef
2.
go back to reference Sharma S, Wood MJ. The global burden of cardiovascular disease in women. Curr Treat Options Cardiovasc Med. 2018;20(10):1–9.CrossRef Sharma S, Wood MJ. The global burden of cardiovascular disease in women. Curr Treat Options Cardiovasc Med. 2018;20(10):1–9.CrossRef
3.
go back to reference Tsao CW, Aday AW, Almarzooq ZI, Anderson CA, Arora P, Avery CL, et al. Heart disease and stroke statistics—2023 update: a report from the American Heart Association. Circulation. 2023;147(8):e93–621.PubMedCrossRef Tsao CW, Aday AW, Almarzooq ZI, Anderson CA, Arora P, Avery CL, et al. Heart disease and stroke statistics—2023 update: a report from the American Heart Association. Circulation. 2023;147(8):e93–621.PubMedCrossRef
4.
go back to reference Kaptoge S, Pennells L, De Bacquer D, Cooney MT, Kavousi M, Stevens G, et al. World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions. Lancet Global Health. 2019;7(10):e1332–45.CrossRef Kaptoge S, Pennells L, De Bacquer D, Cooney MT, Kavousi M, Stevens G, et al. World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions. Lancet Global Health. 2019;7(10):e1332–45.CrossRef
5.
go back to reference Rapsomaniki E, Timmis A, George J, Pujades-Rodriguez M, Shah AD, Denaxas S, et al. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1· 25 million people. Lancet. 2014;383(9932):1899–911.PubMedPubMedCentralCrossRef Rapsomaniki E, Timmis A, George J, Pujades-Rodriguez M, Shah AD, Denaxas S, et al. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1· 25 million people. Lancet. 2014;383(9932):1899–911.PubMedPubMedCentralCrossRef
6.
go back to reference Mahmood SS, Levy D, Vasan RS, Wang TJ. The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective. Lancet. 2014;383(9921):999–1008.PubMedCrossRef Mahmood SS, Levy D, Vasan RS, Wang TJ. The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective. Lancet. 2014;383(9921):999–1008.PubMedCrossRef
7.
go back to reference O’Donnell CJ, Elosua R. Cardiovascular risk factors. Insights from framingham heart study. Revista Española De Cardiología (English Edition). 2008;61(3):299–310.CrossRef O’Donnell CJ, Elosua R. Cardiovascular risk factors. Insights from framingham heart study. Revista Española De Cardiología (English Edition). 2008;61(3):299–310.CrossRef
8.
go back to reference Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76(25):2982–3021.PubMedPubMedCentralCrossRef Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76(25):2982–3021.PubMedPubMedCentralCrossRef
9.
go back to reference Abuelezam NN, El-Sayed AM, Galea S. The health of Arab americans in the United States: an updated comprehensive literature review. Front Public Health. 2018;6:262.PubMedPubMedCentralCrossRef Abuelezam NN, El-Sayed AM, Galea S. The health of Arab americans in the United States: an updated comprehensive literature review. Front Public Health. 2018;6:262.PubMedPubMedCentralCrossRef
10.
go back to reference Katoue MG, Cerda AA, García LY, Jakovljevic M. Healthcare system development in the Middle East and North Africa region: challenges, endeavors and prospective opportunities. Front Public Health. 2022;10:4937.CrossRef Katoue MG, Cerda AA, García LY, Jakovljevic M. Healthcare system development in the Middle East and North Africa region: challenges, endeavors and prospective opportunities. Front Public Health. 2022;10:4937.CrossRef
11.
go back to reference Hammad EA, Alabbadi I, Taissir F, Hajjwi M, Obeidat NM, Alefan Q, et al. Hospital unit costs in Jordan: insights from a country facing competing health demands and striving for universal health coverage. Health Econ Rev. 2022;12(1):1–9.CrossRef Hammad EA, Alabbadi I, Taissir F, Hajjwi M, Obeidat NM, Alefan Q, et al. Hospital unit costs in Jordan: insights from a country facing competing health demands and striving for universal health coverage. Health Econ Rev. 2022;12(1):1–9.CrossRef
13.
go back to reference Mokdad AH, Jaber S, Aziz MIA, AlBuhairan F, AlGhaithi A, AlHamad NM, et al. The state of health in the arab world, 1990–2010: an analysis of the burden of diseases, injuries, and risk factors. Lancet. 2014;383(9914):309–20.PubMedCrossRef Mokdad AH, Jaber S, Aziz MIA, AlBuhairan F, AlGhaithi A, AlHamad NM, et al. The state of health in the arab world, 1990–2010: an analysis of the burden of diseases, injuries, and risk factors. Lancet. 2014;383(9914):309–20.PubMedCrossRef
14.
go back to reference Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2019 (GBD 2019) Socio-Demographic Index (SDI) 1950–2019. In: Seattle USoAIfHMaEI, editor. 2020. Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2019 (GBD 2019) Socio-Demographic Index (SDI) 1950–2019. In: Seattle USoAIfHMaEI, editor. 2020.
15.
go back to reference Benziger CP, Roth GA, Moran AE. The global burden of disease study and the preventable burden of NCD. Global Heart. 2016;11(4):393–7.PubMedCrossRef Benziger CP, Roth GA, Moran AE. The global burden of disease study and the preventable burden of NCD. Global Heart. 2016;11(4):393–7.PubMedCrossRef
16.
go back to reference Vos T, Allen C, Arora M, Barber RM, Bhutta ZA, Brown A, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the global burden of Disease Study 2015. Lancet. 2016;388(10053):1545–602.CrossRef Vos T, Allen C, Arora M, Barber RM, Bhutta ZA, Brown A, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the global burden of Disease Study 2015. Lancet. 2016;388(10053):1545–602.CrossRef
17.
go back to reference Dicker D, Nguyen G, Abate D, Abate KH, Abay SM, Abbafati C, et al. Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the global burden of Disease Study 2017. Lancet. 2018;392(10159):1684–735.CrossRef Dicker D, Nguyen G, Abate D, Abate KH, Abay SM, Abbafati C, et al. Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the global burden of Disease Study 2017. Lancet. 2018;392(10159):1684–735.CrossRef
18.
go back to reference Murray CJ, Callender CS, Kulikoff XR, Srinivasan V, Abate D, Abate KH, et al. Population and fertility by age and sex for 195 countries and territories, 1950–2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2018;392(10159):1995–2051.CrossRef Murray CJ, Callender CS, Kulikoff XR, Srinivasan V, Abate D, Abate KH, et al. Population and fertility by age and sex for 195 countries and territories, 1950–2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2018;392(10159):1995–2051.CrossRef
19.
go back to reference James SL, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the global burden of Disease Study 2017. Lancet. 2018;392(10159):1789–858.CrossRef James SL, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the global burden of Disease Study 2017. Lancet. 2018;392(10159):1789–858.CrossRef
20.
go back to reference Gakidou E, Afshin A, Abajobir AA, Abate KH, Abbafati C, Abbas KM, et al. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the global burden of Disease Study 2016. Lancet. 2017;390(10100):1345–422.CrossRef Gakidou E, Afshin A, Abajobir AA, Abate KH, Abbafati C, Abbas KM, et al. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the global burden of Disease Study 2016. Lancet. 2017;390(10100):1345–422.CrossRef
21.
go back to reference Lozano R, Fullman N, Abate D, Abay SM, Abbafati C, Abbasi N, et al. Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic analysis for the global burden of Disease Study 2017. Lancet. 2018;392(10159):2091–138.CrossRef Lozano R, Fullman N, Abate D, Abay SM, Abbafati C, Abbasi N, et al. Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic analysis for the global burden of Disease Study 2017. Lancet. 2018;392(10159):2091–138.CrossRef
22.
go back to reference Roth G. Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2017 (GBD 2017) Results. Seattle, United States: Institute for Health Metrics and Evaluation (IHME), 2018. The Lancet. 2018;392:1736-88. Roth G. Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2017 (GBD 2017) Results. Seattle, United States: Institute for Health Metrics and Evaluation (IHME), 2018. The Lancet. 2018;392:1736-88.
23.
go back to reference Alsaud W, Tabbaa MJ, Kasabri VN, Suyagh MF, Alsamen MAA, Haddad HM, et al. Prevalence of cardiovascular diseases risk factors among jordanians. J Saudi Heart Association. 2020;32(2):324.PubMedPubMedCentralCrossRef Alsaud W, Tabbaa MJ, Kasabri VN, Suyagh MF, Alsamen MAA, Haddad HM, et al. Prevalence of cardiovascular diseases risk factors among jordanians. J Saudi Heart Association. 2020;32(2):324.PubMedPubMedCentralCrossRef
24.
go back to reference Aho K, Harmsen P, Hatano S, Marquardsen J, Smirnov VE, Strasser T. Cerebrovascular disease in the community: results of a WHO collaborative study. Bull World Health Organ. 1980;58(1):113.PubMedPubMedCentral Aho K, Harmsen P, Hatano S, Marquardsen J, Smirnov VE, Strasser T. Cerebrovascular disease in the community: results of a WHO collaborative study. Bull World Health Organ. 1980;58(1):113.PubMedPubMedCentral
25.
go back to reference Murray CJ, Aravkin AY, Zheng P, Abbafati C, Abbas KM, Abbasi-Kangevari M, et al. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of Disease Study 2019. Lancet. 2020;396(10258):1223–49.CrossRef Murray CJ, Aravkin AY, Zheng P, Abbafati C, Abbas KM, Abbasi-Kangevari M, et al. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of Disease Study 2019. Lancet. 2020;396(10258):1223–49.CrossRef
26.
go back to reference Devleesschauwer B, Havelaar AH, Maertens de Noordhout C, Haagsma JA, Praet N, Dorny P, et al. Calculating disability-adjusted life years to quantify burden of disease. Int J Public Health. 2014;59(3):565–9.PubMedCrossRef Devleesschauwer B, Havelaar AH, Maertens de Noordhout C, Haagsma JA, Praet N, Dorny P, et al. Calculating disability-adjusted life years to quantify burden of disease. Int J Public Health. 2014;59(3):565–9.PubMedCrossRef
27.
go back to reference Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the global burden of Disease Study 2010. Lancet. 2012;380(9859):2163–96.PubMedPubMedCentralCrossRef Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the global burden of Disease Study 2010. Lancet. 2012;380(9859):2163–96.PubMedPubMedCentralCrossRef
28.
go back to reference Safiri S, Kolahi A-A, Smith E, Hill C, Bettampadi D, Mansournia MA, et al. Global, regional and national burden of osteoarthritis 1990–2017: a systematic analysis of the global burden of Disease Study 2017. Ann Rheum Dis. 2020;79(6):819–28.PubMedCrossRef Safiri S, Kolahi A-A, Smith E, Hill C, Bettampadi D, Mansournia MA, et al. Global, regional and national burden of osteoarthritis 1990–2017: a systematic analysis of the global burden of Disease Study 2017. Ann Rheum Dis. 2020;79(6):819–28.PubMedCrossRef
29.
go back to reference Safiri S, Kolahi AA, Cross M, Carson-Chahhoud K, Hoy D, Almasi‐Hashiani A, et al. Prevalence, incidence, and years lived with disability due to gout and its attributable risk factors for 195 countries and territories 1990–2017: a systematic analysis of the global burden of disease study 2017. Arthritis Rheumatol. 2020;72(11):1916–27.PubMedCrossRef Safiri S, Kolahi AA, Cross M, Carson-Chahhoud K, Hoy D, Almasi‐Hashiani A, et al. Prevalence, incidence, and years lived with disability due to gout and its attributable risk factors for 195 countries and territories 1990–2017: a systematic analysis of the global burden of disease study 2017. Arthritis Rheumatol. 2020;72(11):1916–27.PubMedCrossRef
30.
go back to reference Wang H, Abbas KM, Abbasifard M, Abbasi-Kangevari M, Abbastabar H, Abd-Allah F, et al. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the global burden of Disease Study 2019. Lancet. 2020;396(10258):1160–203.CrossRef Wang H, Abbas KM, Abbasifard M, Abbasi-Kangevari M, Abbastabar H, Abd-Allah F, et al. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the global burden of Disease Study 2019. Lancet. 2020;396(10258):1160–203.CrossRef
31.
go back to reference Mokdad A, Tehrani-Banihashemi A, Moradi-Lakeh M, El Bcheraoui C, Charara R, Afshin A, et al. Burden of cardiovascular diseases in the Eastern Mediterranean Region, 1990–2015: findings from the global burden of Disease 2015 study. Int J Public Health. 2018;63(S1):137–49.CrossRef Mokdad A, Tehrani-Banihashemi A, Moradi-Lakeh M, El Bcheraoui C, Charara R, Afshin A, et al. Burden of cardiovascular diseases in the Eastern Mediterranean Region, 1990–2015: findings from the global burden of Disease 2015 study. Int J Public Health. 2018;63(S1):137–49.CrossRef
32.
go back to reference World Health Organization. Noncommunicable diseases country profiles 2014. 2014. World Health Organization. Noncommunicable diseases country profiles 2014. 2014.
33.
go back to reference World Health Organization. STEPS country report. 2017. World Health Organization. STEPS country report. 2017.
34.
go back to reference Ikeda N, Sapienza D, Guerrero R, Aekplakorn W, Naghavi M, Mokdad AH, et al. Control of hypertension with medication: a comparative analysis of national surveys in 20 countries. Bull World Health Organ. 2013;92:10–C9.PubMedPubMedCentralCrossRef Ikeda N, Sapienza D, Guerrero R, Aekplakorn W, Naghavi M, Mokdad AH, et al. Control of hypertension with medication: a comparative analysis of national surveys in 20 countries. Bull World Health Organ. 2013;92:10–C9.PubMedPubMedCentralCrossRef
35.
go back to reference Mahfouz AA, Shatoor AS, Hassanein MA, Mohamed A, Farheen A. Gender differences in cardiovascular risk factors among adolescents in Aseer Region, southwestern Saudi Arabia. J Saudi Heart Association. 2012;24(2):61–7.PubMedCrossRef Mahfouz AA, Shatoor AS, Hassanein MA, Mohamed A, Farheen A. Gender differences in cardiovascular risk factors among adolescents in Aseer Region, southwestern Saudi Arabia. J Saudi Heart Association. 2012;24(2):61–7.PubMedCrossRef
37.
go back to reference Rodgers JL, Jones J, Bolleddu SI, Vanthenapalli S, Rodgers LE, Shah K, et al. Cardiovascular risks associated with gender and aging. J Cardiovasc Dev Disease. 2019;6(2):19.CrossRef Rodgers JL, Jones J, Bolleddu SI, Vanthenapalli S, Rodgers LE, Shah K, et al. Cardiovascular risks associated with gender and aging. J Cardiovasc Dev Disease. 2019;6(2):19.CrossRef
38.
go back to reference Akl C, Akik C, Ghattas H, Obermeyer CM. Gender disparities in midlife hypertension: a review of the evidence on the arab region. Women’s Midlife Health. 2017;3(1):1–10.PubMedPubMedCentralCrossRef Akl C, Akik C, Ghattas H, Obermeyer CM. Gender disparities in midlife hypertension: a review of the evidence on the arab region. Women’s Midlife Health. 2017;3(1):1–10.PubMedPubMedCentralCrossRef
39.
go back to reference Baiden D, Parry M, Nerenberg K, Hillan EM, Dogba MJ. Connecting the dots: structural racism, intersectionality, and cardiovascular health outcomes for African, Caribbean, and black mothers. Health Equity. 2022;6(1):402–5.PubMedPubMedCentralCrossRef Baiden D, Parry M, Nerenberg K, Hillan EM, Dogba MJ. Connecting the dots: structural racism, intersectionality, and cardiovascular health outcomes for African, Caribbean, and black mothers. Health Equity. 2022;6(1):402–5.PubMedPubMedCentralCrossRef
40.
go back to reference Lewis TT, Aiello AE, Leurgans S, Kelly J, Barnes LL. Self-reported experiences of everyday discrimination are associated with elevated C-reactive protein levels in older African-American adults. Brain Behav Immun. 2010;24(3):438–43. Lewis TT, Aiello AE, Leurgans S, Kelly J, Barnes LL. Self-reported experiences of everyday discrimination are associated with elevated C-reactive protein levels in older African-American adults. Brain Behav Immun. 2010;24(3):438–43.
41.
go back to reference Hinton W, McGovern A, Coyle R, Han TS, Sharma P, Correa A et al. Incidence and prevalence of Cardiovascular Disease in English Primary Care: a cross-sectional and Follow-Up study of the Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC). BMJ Open. 2018. Hinton W, McGovern A, Coyle R, Han TS, Sharma P, Correa A et al. Incidence and prevalence of Cardiovascular Disease in English Primary Care: a cross-sectional and Follow-Up study of the Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC). BMJ Open. 2018.
42.
go back to reference Dhungana RR, Thapa P, Devkota S, Banik PC, Gurung Y, Mumu SJ et al. Prevalence of Cardiovascular Disease Risk factors: A Community-based cross-sectional study in a Peri-urban Community of Kathmandu, Nepal. Indian Heart J. 2018. Dhungana RR, Thapa P, Devkota S, Banik PC, Gurung Y, Mumu SJ et al. Prevalence of Cardiovascular Disease Risk factors: A Community-based cross-sectional study in a Peri-urban Community of Kathmandu, Nepal. Indian Heart J. 2018.
43.
go back to reference Shi R. The Relationship Between the Causes of Cardiovascular Diseases. Highlights in Science Engineering and Technology. 2023. Shi R. The Relationship Between the Causes of Cardiovascular Diseases. Highlights in Science Engineering and Technology. 2023.
44.
go back to reference Roth GA, Johnson CO, Abajobir AA, Abd-Allah F, Abera SF, Abyu GY et al. Global, Regional, and National Burden of Cardiovascular diseases for 10 causes, 1990 to 2015. J Am Coll Cardiol. 2017. Roth GA, Johnson CO, Abajobir AA, Abd-Allah F, Abera SF, Abyu GY et al. Global, Regional, and National Burden of Cardiovascular diseases for 10 causes, 1990 to 2015. J Am Coll Cardiol. 2017.
45.
go back to reference Grau M, Subirana I, Vila J, Elosúa R, Ramos R, Sala J et al. Validation of a Population Coronary Disease Predictive System: the CASSANDRA Model. J Epidemiol Community Health. 2014. Grau M, Subirana I, Vila J, Elosúa R, Ramos R, Sala J et al. Validation of a Population Coronary Disease Predictive System: the CASSANDRA Model. J Epidemiol Community Health. 2014.
46.
go back to reference Nanda H, Shivgotra VK, Kumar M. Prevalence of Cardiovascular diseases among the Urban and Rural Geriatric Population of India. Int J Health Sci. 2022. Nanda H, Shivgotra VK, Kumar M. Prevalence of Cardiovascular diseases among the Urban and Rural Geriatric Population of India. Int J Health Sci. 2022.
47.
go back to reference Savonitto S, Colombo D, Franco N, Misuraca L, Lenatti L, Romano I, et al. Age at Menopause and Extent of Coronary Artery Disease among Postmenopausal Women with Acute Coronary syndromes. The American Journal of Medicine; 2016. Savonitto S, Colombo D, Franco N, Misuraca L, Lenatti L, Romano I, et al. Age at Menopause and Extent of Coronary Artery Disease among Postmenopausal Women with Acute Coronary syndromes. The American Journal of Medicine; 2016.
48.
go back to reference Mukattash TL, Shara M, Jarab AS, Al-Azzam SI, Almaaytah A, Al Hamarneh YN. Public knowledge and awareness of cardiovascular disease and its risk factors: a cross-sectional study of 1000 jordanians. Int J Pharm Pract. 2012;20(6):367–76.PubMedCrossRef Mukattash TL, Shara M, Jarab AS, Al-Azzam SI, Almaaytah A, Al Hamarneh YN. Public knowledge and awareness of cardiovascular disease and its risk factors: a cross-sectional study of 1000 jordanians. Int J Pharm Pract. 2012;20(6):367–76.PubMedCrossRef
49.
go back to reference Mosleh SM, Darawad M. Patients’ adherence to healthy behavior in coronary heart disease: risk factor management among Jordanian patients. J Cardiovasc Nurs. 2015;30(6):471–8.PubMedCrossRef Mosleh SM, Darawad M. Patients’ adherence to healthy behavior in coronary heart disease: risk factor management among Jordanian patients. J Cardiovasc Nurs. 2015;30(6):471–8.PubMedCrossRef
50.
go back to reference Darawad MW, Alfasfos N, Saleh Z, Saleh AM, Hamdan-Mansour A. Predictors of delay in seeking treatment by Jordanian patients with acute coronary syndrome. Int Emerg Nurs. 2016;26:20–5.PubMedCrossRef Darawad MW, Alfasfos N, Saleh Z, Saleh AM, Hamdan-Mansour A. Predictors of delay in seeking treatment by Jordanian patients with acute coronary syndrome. Int Emerg Nurs. 2016;26:20–5.PubMedCrossRef
51.
go back to reference Darawad MW, Khalil AA. Jordanian dialysis patients’ perceived exercise benefits and barriers: a correlation study. Rehabilitation Nurs J. 2013;38(6):315–22.CrossRef Darawad MW, Khalil AA. Jordanian dialysis patients’ perceived exercise benefits and barriers: a correlation study. Rehabilitation Nurs J. 2013;38(6):315–22.CrossRef
52.
go back to reference Hammad S, Darawad M, Hourani E, Demeh W. Predictors of glycated hemoglobin among Jordanian diabetic patients. Iran J Public Health. 2015;44(11):1482.PubMedPubMedCentral Hammad S, Darawad M, Hourani E, Demeh W. Predictors of glycated hemoglobin among Jordanian diabetic patients. Iran J Public Health. 2015;44(11):1482.PubMedPubMedCentral
53.
go back to reference Khalil AA, Darawad M, Al Gamal E, Hamdan-Mansour AM, Abed MA. Predictors of dietary and fluid non‐adherence in Jordanian patients with end‐stage renal disease receiving haemodialysis: a cross‐sectional study. J Clin Nurs. 2013;22(1–2):127–36.PubMedCrossRef Khalil AA, Darawad M, Al Gamal E, Hamdan-Mansour AM, Abed MA. Predictors of dietary and fluid non‐adherence in Jordanian patients with end‐stage renal disease receiving haemodialysis: a cross‐sectional study. J Clin Nurs. 2013;22(1–2):127–36.PubMedCrossRef
54.
go back to reference Eshah NF, Bond AE, Froelicher ES. The effects of a cardiovascular disease prevention program on knowledge and adoption of a heart healthy lifestyle in Jordanian working adults. Eur J Cardiovasc Nurs. 2010;9(4):244–53.PubMedCrossRef Eshah NF, Bond AE, Froelicher ES. The effects of a cardiovascular disease prevention program on knowledge and adoption of a heart healthy lifestyle in Jordanian working adults. Eur J Cardiovasc Nurs. 2010;9(4):244–53.PubMedCrossRef
55.
go back to reference Wister A, Loewen N, Kennedy-Symonds H, McGowan B, McCoy B, Singer J. One-year follow-up of a therapeutic lifestyle intervention targeting cardiovascular disease risk. CMAJ. 2007;177(8):859–65.PubMedPubMedCentralCrossRef Wister A, Loewen N, Kennedy-Symonds H, McGowan B, McCoy B, Singer J. One-year follow-up of a therapeutic lifestyle intervention targeting cardiovascular disease risk. CMAJ. 2007;177(8):859–65.PubMedPubMedCentralCrossRef
56.
go back to reference White K, Jacques PH. Combined diet and exercise intervention in the workplace: effect on cardiovascular disease risk factors. AAOHN J. 2007;55(3):109–14.PubMedCrossRef White K, Jacques PH. Combined diet and exercise intervention in the workplace: effect on cardiovascular disease risk factors. AAOHN J. 2007;55(3):109–14.PubMedCrossRef
57.
go back to reference Villareal DT, Miller BV III, Banks M, Fontana L, Sinacore DR, Klein S. Effect of lifestyle intervention on metabolic coronary heart disease risk factors in obese older adults. Am J Clin Nutr. 2006;84(6):1317–23.PubMedCrossRef Villareal DT, Miller BV III, Banks M, Fontana L, Sinacore DR, Klein S. Effect of lifestyle intervention on metabolic coronary heart disease risk factors in obese older adults. Am J Clin Nutr. 2006;84(6):1317–23.PubMedCrossRef
58.
go back to reference Kuller LH, Kinzel LS, Pettee KK, Kriska AM, Simkin-Silverman LR, Conroy MB, et al. Lifestyle intervention and coronary heart disease risk factor changes over 18 months in postmenopausal women: the women on the Move through Activity and Nutrition (WOMAN study) clinical trial. J Women’s Health. 2006;15(8):962–74.CrossRef Kuller LH, Kinzel LS, Pettee KK, Kriska AM, Simkin-Silverman LR, Conroy MB, et al. Lifestyle intervention and coronary heart disease risk factor changes over 18 months in postmenopausal women: the women on the Move through Activity and Nutrition (WOMAN study) clinical trial. J Women’s Health. 2006;15(8):962–74.CrossRef
59.
go back to reference Kaati G, Bygren L-O, Vester M, Karlsson A, Sjöström M. Outcomes of comprehensive lifestyle modification in inpatient setting. Patient Educ Couns. 2006;62(1):95–103.PubMedCrossRef Kaati G, Bygren L-O, Vester M, Karlsson A, Sjöström M. Outcomes of comprehensive lifestyle modification in inpatient setting. Patient Educ Couns. 2006;62(1):95–103.PubMedCrossRef
60.
go back to reference Hardcastle S, Taylor A, Bailey M, Castle R. A randomised controlled trial on the effectiveness of a primary health care based counselling intervention on physical activity, diet and CHD risk factors. Patient Educ Couns. 2008;70(1):31–9.PubMedCrossRef Hardcastle S, Taylor A, Bailey M, Castle R. A randomised controlled trial on the effectiveness of a primary health care based counselling intervention on physical activity, diet and CHD risk factors. Patient Educ Couns. 2008;70(1):31–9.PubMedCrossRef
61.
go back to reference Aldana SG, Greenlaw RL, Diehl HA, Salberg A, Merrill RM, Ohmine S, et al. Effects of an intensive diet and physical activity modification program on the health risks of adults. J Am Diet Assoc. 2005;105(3):371–81.PubMedCrossRef Aldana SG, Greenlaw RL, Diehl HA, Salberg A, Merrill RM, Ohmine S, et al. Effects of an intensive diet and physical activity modification program on the health risks of adults. J Am Diet Assoc. 2005;105(3):371–81.PubMedCrossRef
62.
go back to reference Bayne-Smith M, Fardy PS, Azzollini A, Magel J, Schmitz KH, Agin D. Improvements in heart health behaviors and reduction in coronary artery disease risk factors in urban teenaged girls through a school-based intervention: the PATH program. Am J Public Health. 2004;94(9):1538–43.PubMedPubMedCentralCrossRef Bayne-Smith M, Fardy PS, Azzollini A, Magel J, Schmitz KH, Agin D. Improvements in heart health behaviors and reduction in coronary artery disease risk factors in urban teenaged girls through a school-based intervention: the PATH program. Am J Public Health. 2004;94(9):1538–43.PubMedPubMedCentralCrossRef
63.
go back to reference Saifan AR, Alarabyat IA, Alrimawi I, Al-Nsair N. Utilizing telehealth intervention to support patients with cardiovascular diseases in Jordan: a qualitative study. Appl Nurs Res. 2022;68:151641.PubMedCrossRef Saifan AR, Alarabyat IA, Alrimawi I, Al-Nsair N. Utilizing telehealth intervention to support patients with cardiovascular diseases in Jordan: a qualitative study. Appl Nurs Res. 2022;68:151641.PubMedCrossRef
Metadata
Title
The burden of Cardiovascular diseases in Jordan: a longitudinal analysis from the global burden of disease study, 1990–2019
Authors
Yazan A. Al-Ajlouni
Omar Al Ta’ani
Ghaith Shamaileh
Yazan Nagi
Mohammad Tanashat
Farah Al-Bitar
Dustin T. Duncan
Nour Makarem
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2024
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-024-18316-0

Other articles of this Issue 1/2024

BMC Public Health 1/2024 Go to the issue